Phase I Clinical Trial of Autologous CD7-CAR T Cells in the Treatment of High-risk Acute T-cell Leukemia / Lymphoma
Condition(s):T Cell Lymphoma; T-cell LeukemiaLast Updated:August 15, 2022Recruiting
Include Studies Not Open or Pending
Condition(s):T Cell Lymphoma; T-cell LeukemiaLast Updated:August 15, 2022Recruiting
Condition(s):Adult T-cell Leukemia-Lymphoma; ATLLLast Updated:January 2, 2024Recruiting
Condition(s):Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 InfectionLast Updated:March 6, 2024Recruiting
Condition(s):T-cell Leukemia/Lymphoma; Refractory T Lymphoblastic Leukemia/Lymphoma; Relapse/RecurrenceLast Updated:August 2, 2022Recruiting
Condition(s):Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Adult T-Cell Leukemia/Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaLast Updated:January 31, 2024Recruiting
Condition(s):Prolymphocytic Leukemia; T-cell LeukemiaLast Updated:July 27, 2022Recruiting
Condition(s):T-cell Lymphoma; T-cell LeukemiaLast Updated:March 5, 2024Recruiting
Condition(s):T-Cell Lymphocytic Leukemia; T-Cell Chronic Lymphocytic Leukemia; T Cell Non-Hodgkin LymphomaLast Updated:March 16, 2022Recruiting
Condition(s):NK-Cell Lymphoma; NK-Cell Leukemia; Peripheral T Cell LymphomaLast Updated:October 26, 2023Recruiting
Condition(s):LymphomaLast Updated:June 21, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.